CERo Therapeutics Holdings, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
CERO Company Description
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.
CERO Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view CERO Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of CERO by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CERO's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of CERO in WallStreetBets Daily Discussion
CERO News
Recent insights relating to CERO
CNBC Recommendations
Recent picks made for CERO stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in CERO
Corporate Flights
Flights by private jets registered to CERO
Our Analysis